| Curatis AG - PRILIGY, Filmtabletten | | 60470 | | 01 | | PRILIGY | | Filmtabletten | | G04BX14 | | Dapoxetine | | 19.10.2012 | | |
| | Composition | | dapoxetinum 30 mg ut dapoxetini hydrochloridum, lactosum monohydricum 44 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium max. 0.36 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 2 mg, hypromellosum, E 171, triacetinum, E 172 (nigrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Dapoxetinum | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 2 mg | Überzug | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 3 Tablet(s) | | | B | | No | | 002 | 6 Tablet(s) | | | B | | No |
|
|
